Updated:
Helixmith
Helixmith (KOSDAQ: 084990) is a biotechnology company founded in 1996 in Seoul, South Korea. It develops gene therapies, biopharmaceuticals, novel biologics,...
Helixmith
Helixmith (KOSDAQ: 084990) is a biotechnology company founded in 1996 in Seoul, South Korea. It develops gene therapies, biopharmaceuticals, novel biologics, and herbal therapeutics for diseases such as diabetic foot ulcers, claudication, and amyotrophic lateral sclerosis. The company offers solutions for previously untreated conditions.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Frequently asked questions
What can be confirmed about Helixmith's investment focus?
Nothing. Helixmith's website is gated behind a human-verification process that blocks automated research tools. No primary-source interviews, regulatory filings, or published investor letters have surfaced to confirm its strategy, sector preferences, or asset-class exposure.
Does Helixmith disclose its assets under management?
No. Helixmith has not published an AUM figure in any public filing, press release, or media mention as of mid-2026. The firm provides no data that would allow a third-party estimate.
Who runs Helixmith?
That is unknown. The firm's website, protected behind a bot-detection gate, is the only accessible public source, and it does not reveal team rosters, founder names, or leadership titles on indexed pages. No alternative primary source fills this gap.
Where is Helixmith located and does it have additional offices?
Seoul, South Korea is the only confirmed location. No secondary offices have been identified through public records, press, or the firm's own minimal digital footprint.
Is Helixmith a family office or another type of entity?
Unknown. The limited observable data does not clarify whether Helixmith operates as a single-family office, multi-family office, asset manager, or another structure. Its entity type has not been stated publicly.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: